Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOCOCIZUMAB for Angina pectoris: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where BOCOCIZUMAB was used for Angina pectoris.

Most Reported Side Effects for BOCOCIZUMAB

Side Effect Reports % Deaths Hosp.
Anaemia 34 27.9% 0 32
Hypotension 34 27.9% 0 33
Angina pectoris 32 26.2% 0 31
Presyncope 32 26.2% 0 31
Psoriasis 32 26.2% 0 31
Pulmonary oedema 32 26.2% 0 31
Cardiac failure 31 25.4% 0 30
Contusion 31 25.4% 0 30
Fluid retention 31 25.4% 0 30
Oedema peripheral 31 25.4% 0 30
Ventricular dysfunction 29 23.8% 0 28
Drug interaction 13 10.7% 0 13
Condition aggravated 8 6.6% 0 8
Cardiac failure congestive 7 5.7% 0 6
Dyspnoea 7 5.7% 0 7

Other Indications for BOCOCIZUMAB

Cardiovascular disorder (103) Hyperlipidaemia (11)

Other Drugs Used for Angina pectoris

RANOLAZINE (6,036) NITROGLYCERIN (970) DILTIAZEM (674) ASPIRIN (429) AMLODIPINE (427) ISOSORBIDE MONONITRATE (221) ACEBUTOLOL (217) CLOPIDOGREL BISULFATE (193) IVABRADINE (191) QUINAPRIL (181)

Related Pages

BOCOCIZUMAB Full Profile All Angina pectoris Drugs BOCOCIZUMAB Demographics BOCOCIZUMAB Timeline